Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone adjunctive extension study in bipolar I disorder
2011-004789-14Phase 3Completed
- Sponsor
- Sunovion
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lurasidone in bipolar I disorder and bipolar disorder (BD), sponsored by Sunovion. Primary endpoint: Safety and tolerability. Started May 2012; status: completed.
02
Drugs
lurasidone
03
Conditions
bipolar I disorderbipolar disorder (BD)
Beyond the preview
Go deeper on 2011-004789-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004789-14.